Carlyle Group, along with co-investors King Street Capital Management and Davidson Kempner Capital Management, is reportedly considering a renewed sale of Trans Maldivian Airways Pvt (TMA), the world’s largest seaplane operator, according to a report by Bloomberg.
UK mid-market private equity investor Livingbridge has made an investment in Kindred Education Limited (Kindred), a provider of early years education for children aged 0-5 years, through its Enterprise 3 Fund.
ICV Partners, a private equity investment firm focused on middle-market companies, has appointed Lloyd Metz and Zeena Rao as Managing Partners. Rao joined ICV in 2001, while Metz has been with the business since 2002.
Hillhouse Investment has recruited Tomohiro Kikuta, a former partner at Bain Capital, to lead its expansion in Japan amid a surge in deal-making activities, according to a report by Reuters citing unnamed sources familiar with the matter.
Private equity giant Carlyle Group is pursuing at least AUD500m ($324m) in debt financing to support its acquisition of Waste Services Group, an Australian waste management firm, from Livingbridge EP, according to a report by Bloomberg.
Private equity giant TPG is exploring the sale of Crunch Fitness, a gym chain that could be valued at over $1.5bn, including debt, according to a report by Reuters citing sources familiar with the matter.
Blue Earth Capital (BlueEarth), a specialist global impact investor, has held the first closing of its first evergreen, semi-liquid impact private credit strategy fund with capital commitments totalling €113m from a ‘select group’ of anchor investors.
Scottish Equity Partners (SEP), a UK based growth equity investor, has made a strategic growth investment in Springtime Technologies (Springtime), an accounts payable automation software company based in Vienna, Austria.
Following on from the success of its inaugural €250m private debt fund, Investec Alternative Investment Management (IAIM), a subsidiary of Investec Bank plc (Investec), has held the first close of its second Private Debt Fund (PDF II) at €200m.
Abingworth, a life sciences investment firm backed by private investment major Carlyle, is seeking to raise up to $1.5bn for a new fund aimed at financing late-stage clinical trials, according to a report by the Financial Times.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
